Search for: "WARNER V. WARNER"
Results 481 - 500
of 2,295
Sort by Relevance
|
Sort by Date
4 Jun 2018, 1:00 am
Warner-Lambert Company LLC v Generics (UK) Ltd t/a Mylan & Anor, heard 12-15 Feb 2018. [read post]
1 Jun 2018, 1:10 pm
Warner v. [read post]
31 May 2018, 7:53 am
For example, in addition to those points raised above, an area which has been subject to much debate is the appropriate remedy for cross-label infringement of second medical use patents – this may come as a result of the Supreme Court’s pending decision in Warner-Lambert v Actavis (if the patent is found to be valid and infringed), or we may have to wait a little longer. [read post]
25 May 2018, 9:27 am
Following on from the Warner-Lambert v Actavis [2015] EWHC 485 (Pat) (prescription by brand) Fujifilm v AbbVie [2017] EWHC 395 (Pat) (Arrow declaration) and Unwired Planet v Huawei [2017] EWHC 2988 (Pat) (global FRAND terms) decisions, this provides another example of the UK Patents Court providing highly specific and tailored relief appropriate to the facts of the case. [read post]
24 May 2018, 7:35 am
Viacom Int’l, Inc. v. [read post]
21 May 2018, 1:00 am
Warner-Lambert Company LLC v Generics (UK) Ltd t/a Mylan & Anor, heard 12-15 Feb 2018. [read post]
19 May 2018, 12:44 pm
Time Warner Cable Texas, LLC, 2017 WL 5985573, at *5 (W.D. [read post]
17 May 2018, 3:15 am
Back in 1967, the Supreme Court ruled in Afroyim v. [read post]
15 May 2018, 9:01 pm
In Miller v. [read post]
14 May 2018, 1:00 am
Warner-Lambert Company LLC v Generics (UK) Ltd t/a Mylan & Anor, heard 12-15 Feb 2018. [read post]
7 May 2018, 1:00 am
Warner-Lambert Company LLC v Generics (UK) Ltd t/a Mylan & Anor, heard 12-15 Feb 2018. [read post]
6 May 2018, 9:10 am
In Warner v. [read post]
3 May 2018, 10:40 am
Warner Bros. [read post]
1 May 2018, 7:38 am
Warner Bros. [read post]
30 Apr 2018, 1:00 am
Warner-Lambert Company LLC v Generics (UK) Ltd t/a Mylan & Anor, heard 12-15 Feb 2018. [read post]
23 Apr 2018, 1:00 am
Warner-Lambert Company LLC v Generics (UK) Ltd t/a Mylan & Anor, heard 12-15 Feb 2018. [read post]
22 Apr 2018, 8:40 am
Keta Lomidze and Alasdhair McDonald, who both work within the intellectual property team at CMS, preview the decision awaited in Warner-Lambert Company LLC v Generics (UK) Ltd t/a Mylan & Anor: A highly publicised dispute, concerning second medical use protection of the drug Pregabalin, has finally reached the Supreme Court and is currently awaiting its decision. [read post]
22 Apr 2018, 3:15 am
Robotx Solutions Inc. v. [read post]
16 Apr 2018, 1:00 am
Warner-Lambert Company LLC v Generics (UK) Ltd t/a Mylan & Anor, heard 12-15 Feb 2018. [read post]
15 Apr 2018, 1:55 pm
Thus, where "the existence of coverage depends entirely on the applicability of [an] exception to the exclusion, the insured has the duty of demonstrating that it has been satisfied" (Borg-Warner Corp. v Insurance Co. of N. [read post]
